| Literature DB >> 15345053 |
Jing Wang1, Laura Kean, Jingli Yang, Adrian K Allan, Shireen A Davies, Pawel Herzyk, Julian A T Dow.
Abstract
BACKGROUND: Comprehensive, tissue-specific, microarray analysis is a potent tool for the identification of tightly defined expression patterns that might be missed in whole-organism scans. We applied such an analysis to Drosophila melanogaster Malpighian (renal) tubule, a defined differentiated tissue.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15345053 PMCID: PMC522876 DOI: 10.1186/gb-2004-5-9-r69
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
Figure 1Scatterplot of mean whole fly vs tubule signal intensities. Genes called as significantly enriched in tubule compared with fly by MAS 5.0 are in red, those significantly depleted in blue, and those not significantly different in yellow.
Most abundant genes in tubule, sorted by normalized Affymetrix signal strength
| Gene | Signal | Enrichment | Function |
| 12,114 ± 581 | 3.0 ± 0.0 | Cu-binding | |
| 10,672 ± 518 | 7.4 ± 0.4 | ||
| 10,392 ± 572 | 8.4 ± 0.5 | ||
| 10,199 ± 459 | 6.2 ± 0.3 | Transporter | |
| 9,368 ± 276 | 1.3 ± 0.0 | Small-subunit cytosol ribosomal protein | |
| 8,895 ± 395 | 1.3 ± 0.0 | Alcohol dehydrogenase; EC 1.1.1.1 | |
| 8,720 ± 226 | 1.2 ± 0.0 | Small-subunit cytosol ribosomal protein | |
| 7,818 ± 370 | 3.9 ± 0.6 | ||
| 7,767 ± 305 | 13.4 ± 2.3 | ||
| 7,757 ± 198 | 1.3 ± 0.0 | Large-subunit cytosol ribosomal protein | |
| 7,711 ± 160 | 1.7 ± 0.0 | ||
| 7,514 ± 200 | 1.4 ± 0.0 | Large-subunit cytosol ribosomal protein | |
| 7,483 ± 209 | 1.3 ± 0.0 | Large-subunit cytosol ribosomal protein | |
| 7,481 ± 283 | 1.3 ± 0.1 | Cytosolic ribosomal protein | |
| 7,307 ± 244 | 14.4 ± 0.5 | Peptidase | |
| 7,284 ± 254 | 1.2 ± 0.1 | Large-subunit cytosol ribosomal protein | |
| 7,250 ± 165 | 1.1 ± 0.1 | Structural protein of ribosome | |
| 7,211 ± 329 | 36.8 ± 6.5 | Transporter | |
| 7,179 ± 105 | 1.4 ± 0.1 | Large-subunit cytosol ribosomal protein | |
| 7,088 ± 466 | 12.0 ± 1.4 | Enzyme | |
| 7,024 ± 219 | 1.3 ± 0.1 | L17-like | |
| 6,989 ± 177 | 1.3 ± 0.1 | Structural protein of ribosome | |
| 6,890 ± 142 | 1.7 ± 0.0 | ATP synthase alpha subunit | |
| 6,742 ± 278 | 5.0 ± 0.3 | Enzyme | |
| 6,709 ± 240 | 1.3 ± 0.1 | DNA-(apurinic or apyrimidinic site) lyase | |
| 6,603 ± 169 | 1.3 ± 0.1 | Structural protein of ribosome | |
| 6,543 ± 174 | 1.3 ± 0.1 | Structural protein of ribosome | |
| 6,502 ± 171 | 1.2 ± 0.0 | Small-subunit cytosol ribosomal protein | |
| 6,463 ± 105 | 1.3 ± 0.0 | Protein kinase C binding protein | |
| 6,416 ± 190 | 3.1 ± 0.3 | V-ATPase E subunit | |
| 6,305 ± 2100 | 0.6 ± 0.2 | Serine carboxypeptidase | |
| 6,300 ± 2119 | 0.6 ± 0.2 | Serine-type endopeptidase | |
| 6,258 ± 172 | 1.2 ± 0.1 | Structural protein of ribosome | |
| 6,251 ± 217 | 1.3 ± 0.1 | Large-subunit cytosol ribosomal protein | |
| 6,240 ± 151 | 4.2 ± 0.1 | Na, K-ATPase alpha subunit | |
| 6,234 ± 167 | 32.3 ± 2.6 | Sarcosine oxidase | |
| 6,080 ± 151 | 1.3 ± 0.1 | Small-subunit cytosol ribosomal protein | |
| 6,070 ± 157 | 1.1 ± 0.0 | Small-subunit cytosol ribosomal protein | |
| 6,060 ± 113 | 1.2 ± 0.0 | Large-subunit cytosol ribosomal protein | |
| 6,034 ± 122 | 1.6 ± 0.0 | Enzyme | |
| 6,027 ± 270 | 1.9 ± 0.1 | ||
| 5,977 ± 309 | 1.4 ± 0.1 | Structural protein of ribosome | |
| 5,940 ± 176 | 1.3 ± 0.1 | Ribosomal protein | |
| 5,874 ± 79 | 4.2 ± 0.1 | ||
| 5,850 ± 281 | 1.2 ± 0.1 | Structural protein of ribosome | |
| 5,845 ± 215 | 2.6 ± 0.1 | V-ATPase c subunit | |
| 5,820 ± 201 | 1.5 ± 0.1 |
Genes enriched more than 25-fold in tubules
| Gene | Product | MAS enrichment |
| 98.9 | ||
| 95.9 | ||
| 85.2 | ||
| 80.6 | ||
| Potassium channel protein-like | 80.3 | |
| 55.4 | ||
| 54.0 | ||
| 53.8 | ||
| 49.9 | ||
| 47.8 | ||
| 45.5 | ||
| 43.5 | ||
| 40.9 | ||
| 40.6 | ||
| Glutathione transferase | 39.5 | |
| 38.7 | ||
| Organic cation transporter | 36.8 | |
| Monocarboxylate transporter-like | 36.6 | |
| Sodium-dependent multivitamin transporter-like | 35.8 | |
| 34.8 | ||
| Sugar transporter | 34.5 | |
| 33.5 | ||
| 33.4 | ||
| Sugar transporter-like | 33.0 | |
| 32.3 | ||
| ATP-binding cassette (ABC) transporter | 32.3 | |
| Sugar transporter-like | 32.1 | |
| 4-nitrophenylphosphatase-like | 31.2 | |
| 30.5 | ||
| Cation amino-acid symporter | 30.1 | |
| 29.7 | ||
| 29.3 | ||
| Organic anion transporter | 29.3 | |
| 29.3 | ||
| Alkaline phosphatase-like | 29.2 | |
| Iodide symporter-like | 29.1 | |
| 29.0 | ||
| 28.9 | ||
| ATP-binding cassette transporter | 28.3 | |
| Sodium iodide symporter | 27.7 | |
| 27.6 | ||
| 27.4 | ||
| Aryldialkylphosphatase | 27.4 | |
| Sodium phosphate cotransporter | 27.1 | |
| Sodium iodide symporter-like | 27.1 | |
| 26.9 | ||
| Na phosphate cotransporter | 26.8 | |
| Sodium phosphate cotransporter | 26.8 | |
| Cytochrome b561-like | 26.6 | |
| 26.6 | ||
| Organic cation transporter-like | 26.4 | |
| Sodium-dependent multivitamin transporter-like | 25.9 | |
| Cytochrome P450, CYP6A18 | 25.5 |
Validation of array data by QRT-PCR
| Gene | MAS enrichment | SAM enrichment | QRT-PCR enrichment |
| Highly enriched | |||
| 98.9 | 8.7 | 9.0 | |
| 95.9 | 21.9 | 23.8 | |
| 22.6 | 17.4 | 110 | |
| 80.6 | 30.1 | 11.7 | |
| Evenly expressed | |||
| CG17737 | 1.0 | 0.9 | 0.74 |
| CG10731 | 1.0 | 1.1 | 0.68 |
| CG8327 | 1.0 | 0.8 | 1.2 |
| Arp66 | 1.0 | 1.1 | 0.47 |
| Highly depleted | |||
| 0.00 | 0.067 | 0.19 | |
| 0.01 | 0.11 | 0.14 | |
| 0.01 | 0.14 | 0.03 | |
| 0.01 | 0.082 | 0.008 |
Enrichment in tubule mRNA compared to whole fly mRNA, computed from the microarray dataset with MAS 5.0 or SAM (see text), were compared with real values obtained by QRT-PCR. Four separate fly and tubule samples were run with primers for each gene, and for rp49, a ribosomal gene generally considered to be invariant. RNA quantities were calculated, and the gene:rp49 ratio calculated for each sample pair. Tubule enrichment was calculated as the (gene:rp49)tubule/(gene:rp49)fly.
Figure 2Semi-quantitative inter-gene comparison is possible using Affymetrix signal. The 24 QRT-PCR results underlying Table 3 were normalized against rp49, and plotted against the Affymetrix signal globally normalized as in MAS 5.0. Spearman's r was calculated, and significance of the correlation assessed (one-tailed), using Graphpad Prism 3.0.
Figure 3The phenotype gap. Genes enriched in tubules are historically under-researched. The percentage of genes with explicit names (other than automatic CG annotations) is shown for the entire genome, and for the top 50, 100 and 200 genes (as judged by fold enrichment) from the tubule dataset.
Transporters sorted by class
| Gene/class | Signal | Enrichment |
| ATP-binding cassette (ABC) transporter (6/46) | ||
| 1,521 ± 34 | 32 ± 2.8 | |
| 290 ± 25 | 28 ± 3.4 | |
| 422 ± 21 | 21 ± 2.7 | |
| 798 ± 53 | 10 ± 1.4 | |
| 18 ± 2 | 4 ± 1.2 | |
| 72 ± 6 | 3 ± 0.2 | |
| Cationic amino-acid transporter (1/5) | ||
| 308 ± 34 | 7 ± 0.8 | |
| Copper transporter (1/6) | ||
| 374 ± 6 | 5 ± 0.6 | |
| Monocarboxylate transporter (4/14) | ||
| 2,567 ± 82 | 37 ± 2.1 | |
| 1,377 ± 67 | 10 ± 0.7 | |
| 698 ± 38 | 4 ± 0.2 | |
| 550 ± 15 | 3 ± 0.1 | |
| Multidrug efflux transporter (1/6) | ||
| 1,366 ± 68 | 6 ± 0.4 | |
| Pyrimidine-sugar transporter of Golgi (1/1) | ||
| 877 ± 40 | 5 ± 0.3 | |
| Oligopeptide transporter (1/3) | ||
| 517 ± 12 | 10 ± 1.2 | |
| Organic anion transporter (3/5) | ||
| 1,076 ± 56 | 29 ± 3.3 | |
| 3,385 ± 126 | 24 ± 1.6 | |
| 678 ± 90 | 9 ± 2.4 | |
| Organic cation transporter (11/21) | ||
| 7,211 ± 329 | 37 ± 6.5 | |
| 472 ± 13 | 26 ± 5.5 | |
| 1,331 ± 34 | 25 ± 4.2 | |
| 3,152 ± 200 | 23 ± 3.2 | |
| 4,847 ± 37 | 21 ± 2.1 | |
| 36 ± 5 | 7 ± 2.4 | |
| 10,199 ± 459 | 6 ± 0.3 | |
| 269 ± 30 | 5 ± 1.0 | |
| 20 ± 2 | 5 ± 1.5 | |
| 274 ± 29 | 4 ± 0.6 | |
| Reduced folate transporter (2/3) | ||
| 584 ± 22 | 13 ± 1.6 | |
| 190 ± 8 | 4 ± 0.3 | |
| Sodium bicarbonate cotransporter (1/1) | ||
| 531 ± 34 | 5 ± 0.5 | |
| Sodium-dependent inorganic phosphate cotransporter (1 / 20) | ||
| 1,430 ± 428 | 27 ± 2.3 | |
| Sodium-dependent multivitamin transporter (4/5) | ||
| 1,363 ± 30 | 36 ± 3.9 | |
| 2,106 ± 130 | 26 ± 1.4 | |
| 365 ± 10 | 4 ± 0.4 | |
| 6 ± 1 | 3 ± 0.7 | |
| Glucose transporter (3/17) | ||
| 4,951 ± 171 | 16 ± 0.8 | |
| 302 ± 12 | 6 ± 1.0 | |
| 342 ± 24 | 3 ± 0.2 | |
| Sugar transporter (7/7) | ||
| 5,322 ± 186 | 35 ± 2.8 | |
| 1,405 ± 55 | 33 ± 1.3 | |
| 3,774 ± 131 | 32 ± 4.8 | |
| 840 ± 44 | 25 ± 2.1 | |
| 1,210 ± 56 | 22 ± 2.0 | |
| 3,333 ± 194 | 21 ± 1.7 | |
| 1,277 ± 88 | 19 ± 2.9 | |
| Zinc transporter (4/6) | ||
| 3,608 ± 91 | 10 ± 1.0 | |
| 378 ± 19 | 5 ± 0.4 | |
| 919 ± 59 | 4 ± 0.3 | |
| 104 ± 10 | 4 ± 0.6 | |
For brevity, only family members enriched by more than threefold are shown. For each grouping, the numbers in parentheses refer to the number of genes enriched in tubule, compared to the total number of such genes in the Drosophila genome, as classified by Gene Ontology. Where original gene names have been superseded by later annotations of the Drosophila genes, the new names are shown in parentheses.
V-ATPase genes that are enriched in tubule
| Subunit | Copy number | Genes | Affymetrix reference | Signal | Enrichment |
| V1 sector | |||||
| A | 3 | 142380_at | 9 ± 2 | 0.5 ± 0.1 | |
| 146305_at | |||||
| 146306_at | 2 ± 0 | 0.04 ± 0.02 | |||
| B | 1 | 153041_at | |||
| SFD (H) | 1 | 144191_at | |||
| C | 1 | 153422_at | |||
| D | 3 | 152480_at | |||
| 147073_at | 2 ± 0.4 | 0.1 ± 0.0 | |||
| 144407_at | 29 ± 4 | 0.6 ± 0.09 | |||
| E | 1 | 151930_at | |||
| F | 2 | 143625_at | |||
| 149368_at | 5.6 ± 1.6 | 1.5 ± 1.1 | |||
| G | 1 | 144156_at | |||
| V0 sector | |||||
| A | 5 | 153997_at | 155 ± 8 | 0.8 ± 0.0 | |
| 142661_at | |||||
| not on array | |||||
| 146249_at | 306 ± 26 | 1.3 ± 0.1 | |||
| 141662_at | 66 ± 3 | 0.24 ± 0.04 | |||
| c | 5 | 141528_at | |||
| 148578_at | 32 ± 7 | 1.4 ± 0.22 | |||
| ( | |||||
| 147341_at | 18 ± 4 | 1.4 ± 0.6 | |||
| 146189_at | 36 ± 7 | 0.6 ± 0.12 | |||
| PPA1 | 2 | 142158_at | |||
| (c") | 149926_at | 57 ± 7 | 0.9 ± 0.1 | ||
| M9.7 | 3 | 154011_at | 101 ± 9 | ||
| (e, H) | 148161_at | 14 ± 1 | 0.1±0.0 | ||
| 149187_at | |||||
| AC39 | 2 | 154279_at | 2,082 ± 52 | ||
| (d) | 150428_at | 13 ± 2 | 0.8 ± 0.12 |
All genes significantly similar to known human or yeast V-ATPase subunits were identified by BLAST search, extending our previously reported annotation of the V-ATPase family [53], by identifying the genes underlined above as V-ATPase subunits. For comparison, enrichment ratios significantly greater than 1 and signals over 1,000 are shown in bold. (vha16-2 and vha16-3 are in tandem repeat and share the same Affymetrix oligo set, and so cannot be distinguished here.)
Na+, K+-ATPase
| Gene | Signal | Enrichment |
| α-subunit | ||
| 6,240 ± 151 | 4.22 ± 0.05 | |
| 6 ± 1 | 0.85 ± 0.17 | |
| β-subunit | ||
| 1,924 ± 71 | 3.47 ± 0.21 | |
| 2 ± 1 | 0.09 ± 0.06 | |
| 7 ± 2 | 0.46 ± 0.18 | |
| 4 ± 0 | 0.18 ± 0.04 | |
| 20 ± 1 | 0.1 ± 0.01 |
Although the Drosophila Na+, K+-ATPase has classically been thought to be composed of a dimer of Atpalpha and either Nrv1 or Nrv2, the other genes here are more similar by BLASTX to the corresponding alpha and beta subunits than any other gene (data not shown). They are thus included in the table as candidate alternative subunits.
Potassium channels and symporters
| Gene | Signal | Enrichment |
| Potassium channels | ||
| 2771 ± 145 | 80.31 ± 7.75 | |
| 1302 ± 112 | 14.19 ± 1.58 | |
| 527 ± 33 | 5.69 ± 0.24 | |
| 101 ± 0 | 6.44 ± 2.31 | |
| 111 ± 10 | 2.84 ± 0.46 | |
| 29 ± 7 | 3.74 ± 1.12 | |
| 5 ± 2 | 2.6 ± 1.05 | |
| 5 ± 3 | 2.23 ± 1.19 | |
| 6 ± 2 | 2.31 ± 0.84 | |
| 101 ± 11 | 2.15 ± 0.51 | |
| 12 ± 5 | 1.48 ± 0.76 | |
| 8 ± 1 | 1.59 ± 0.39 | |
| 6 ± 1 | 1.38 ± 0.54 | |
| 4 ± 0 | 1.62 ± 0.28 | |
| 26 ± 4 | 1.21 ± 0.54 | |
| 15 ± 4 | 1.31 ± 0.35 | |
| 26 ± 4 | 1.42 ± 0.23 | |
| 3 ± 1 | 1.32 ± 0.22 | |
| 29 ± 4 | 1.19 ± 0.29 | |
| 6 ± 1 | 1.09 ± 0.09 | |
| 41 ± 3 | 0.9 ± 0.1 | |
| 7 ± 3 | 0.65 ± 0.25 | |
| 8 ± 1 | 0.77 ± 0.12 | |
| 13 ± 3 | 0.45 ± 0.13 | |
| 28 ± 2 | 0.32 ± 0.03 | |
| 10 ± 2 | 0.21 ± 0.04 | |
| 6 ± 1 | 0.21 ± 0.04 | |
| 4 ± 1 | 0.14 ± 0.07 | |
| 5 ± 2 | 0.1 ± 0.04 | |
| 4 ± 1 | 0.07 ± 0.01 | |
| Calcium-activated potassium channels | ||
| 21 ± 5 | 1.93 ± 1.06 | |
| 2 ± 0 | 0.11 ± 0.02 | |
| 4 ± 1 | 1.55 ± 0.91 | |
| Potassium-dependent sodium-calcium exchangers | ||
| 39 ± 1 | 1.32 ± 0.12 | |
| 35 ± 2 | 0.81 ± 0.13 | |
| 5 ± 1 | 0.48 ± 0.19 | |
| 31 ± 5 | 0.38 ± 0.05 | |
| 8 ± 2 | 0.24 ± 0.07 | |
| 31 ± 5 | 0.11 ± 0.05 | |
| Sodium/potassium/chloride symporter | ||
| 132 ± 6 | 2.46 ± 0.36 | |
| 185 ± 25 | 1.75 ± 0.22 | |
| 65 ± 5 | 0.8 ± 0.07 | |
| 60 ± 6 | 0.42 ± 0.06 | |
| 12 ± 4 | 0.12 ± 0.04 | |
Chloride channels
| Gene | Signal | Enrichment |
| 251 ± 9 | 4 ± 0.29 | |
| 57 ± 5 | 0.86 ± 0.09 | |
| 100 ± 5 | 2.2 ± 0.16 |
These are the three genes with clear similarity to the ClC gene family of vertebrates [12].
Aquaporins and other major intrinsic proteins
| Gene | Signal | Enrichment |
| 1666 ± 167 | 2.7 ± 0.3 | |
| 705 ± 91 | 7.9 ± 0.9 | |
| 318 ± 16 | 3.6 ± 0.4 | |
| 243 ± 11 | 0.6 ± 0.06 | |
| 22 ± 3 | 0.5 ± 0.04 | |
| 8 ± 1 | 0.2 ± 0.05 | |
| 2 ± 1 | 1.1 ± 0.3 |
Receptors called as upregulated in tubule, with enrichments more than threefold
| Gene | Signal | Enrichment |
| 85 ± 11 | 27 ± 11 | |
| 633 ± 48 | 17 ± 2 | |
| 288 ± 27 | 14 ± 2 | |
| 34 ± 2 | 13 ± 8 | |
| 311 ± 24 | 11 ± 1 | |
| 40 ± 4 | 8.5 ± 0.9 | |
| 9 ± 3 | 8 ± 3.6 | |
| 564 ± 35 | 7 ± 0.9 | |
| 203 ± 17 | 6.7 ± 9 | |
| 221 ± 12 | 6.4 ± 0.5 | |
| 143 ± 8 | 5.0 ± 0.9 | |
| 59 ± 13 | 5 ± 2 | |
| 85 ± 8 | 4.3 ± 0.6 | |
| 294 ± 26 | 4.2 ± 0.5 | |
| 42 ± 5 | 4 ± 1.7 | |
| 24 ± 4 | 4 ± 1.5 | |
| 239 ± 21 | 3.5 ± 0.4 | |
| 142 ± 7 | 2.9 ± 0.4 |
Major genes of the cAMP, cGMP and calcium signaling pathways
| Function | Gene name | Signal | Enrichment | Comments |
| cAMP | ||||
| Adenylate cyclase | 121 ± 12 | 1.4 ± .2 | ||
| 44 ± 5 | 7.2 ± 1.6 | |||
| 106 ± 4 | 4.1 ± 0.5 | |||
| Protein kinase A | 88 ± 9 | 1.7 ± 0.2 | Catalytic subunit | |
| 183 ± 13 | 1.2 ± 0.1 | Regulatory subunit | ||
| PDE | 147 ± 6 | 3.9 ± 0.6 | cAMP-specific | |
| Calcium | ||||
| CamKinase | 112 ± 10 | 1.7 ± 0.2 | ||
| Phospholipase C | 46 ± 6 | 1.1 ± 0.2 | ||
| 58 ± 5 | 1.1 ± 0.1 | |||
| Calcium release channels | 11 ± 2 | 1.2 ± 0.2 | InsP3 receptor | |
| Calmodulin | 1,019 ± 57 | 0.9 ± 0.06 | ||
| Protein kinase C | 217 ± 15 | 1.7 ± 0.2 | ||
| cGMP | ||||
| Guanylate cyclase | 13 ± 3 | 6 ± 2.5 | Probably soluble beta subunit | |
| 410 ± 23 | 2.9 ± 0.4 | Membrane form | ||
| 23 ± 4 | 0.8 ± 0.2 | Membrane form | ||
| 137 ± 5 | 2.0 ± 0.7 | Membrane form | ||
| 20 ± 4 | 0.8 ± 0.1 | Cytoplasmic, beta subunit | ||
| 9 ± 3 | 3.5 ± 1.4 | Membrane form | ||
| PDE | 182 ± 4 | 3.7 ± 0.6 | cGMP-specific, PDE11-like | |
| Protein kinase G | 91 ± 2 | 0.3 ± 0.01 | ||
| 448 ± 20 | 15.7 ± 2.3 | |||
| Serine/threonine protein phosphatases | ||||
| 258 ± 32 | 4.3 ± 0.6 | PPA-2C like | ||
| 228 ± 11 | 2.5 ± 0.2 | Multifunctional | ||
| 209 ± 11 | 2.0 ± 0.1 | PPA-2A like | ||
| 738 ± 28 | 1.9 ± 0.2 | PPA-2A like | ||
| 997 ± 46 | 1.3 ± 0.1 | PPA-2A like | ||
| 318 ± 17 | 1.1 ± 0 | PPA-1 like | ||
| 332 ± 8 | 1.1 ± 0 | PPA-1 like | ||
| Accessory proteins, associated with anchoring, cellular localization or modulation of signaling | ||||
| 136 ± 6 | 2 ± 0.3 | A-kinase anchor protein | ||
| 414 ± 30 | 0.35 ± 0.02 | |||
| 1,789 ± 42 | 2.6 ± 0.2 | Diacylglycerol-activated PKC inhibitor | ||
| 42 ± 4 | 2.7 ± 0.4 | Calcineurin | ||
| 6,463 ± 105 | 1.3 ± 0 | Receptor for activated C-kinase | ||
Transcription factors and DNA-binding proteins that are abundant or enriched in tubule
| Gene | Signal | Enrichment |
| 175 ± 7 | 24.1 ± 11.5 | |
| 50 ± 4 | 19.3 ± 6.2 | |
| 63 ± 5 | 17.5 ± 4.8 | |
| 5771 ± 317 | 16.8 ± 0.7 | |
| 183 ± 8 | 12.7 ± 2.2 | |
| 51 ± 17 | 9.8 ± 3.1 | |
| 91 ± 4 | 8.8 ± 4.3 | |
| 6 ± 1 | 7.7 ± 6.9 | |
| 266 ± 26 | 7.2 ± 1.1 | |
| 162 ± 13 | 7.2 ± 0.7 | |
| 17 ± 2 | 7.1 ± 4.2 | |
| 71 ± 5 | 7.1 ± 0.7 | |
| 5 ± 1 | 6.7 ± 2.4 | |
| 5 ± 1 | 6.0 ± 3.0 | |
| 5 ± 2 | 6.0 ± 5.5 | |
| 287 ± 21 | 5.4 ± 0.9 | |
| 21 ± 4 | 4.8 ± 1.4 | |
| 8 ± 1 | 4.7 ± 2.1 | |
| 145 ± 12 | 4.6 ± 0.8 | |
| 10 ± 1 | 4.6 ± 1.5 | |
| 65 ± 5 | 4.6 ± 0.8 | |
| 45 ± 11 | 4.5 ± 0.6 | |
| 16 ± 2 | 4.3 ± 1.8 | |
| 11 ± 3 | 4.3 ± 1.7 | |
| 31 ± 4 | 4.2 ± 1.7 | |
| 4 ± 2 | 4.1 ± 3.1 | |
| 13 ± 3 | 4.0 ± 1.1 | |
| 18 ± 3 | 4.0 ± 0.4 | |
| 337 ± 17 | 3.9 ± 0.6 | |
| 27 ± 4 | 3.9 ± 1.1 |
Figure 4Expression patterns in tubules of some of the transcription factor genes indicated by the microarray data as being expressed in tubules. (a) homothorax (hth05745), principal and stellate cells of initial and transitional segments only; (b) polyhomeotic proximal (ph-p), all cells of tubule, and midgut; (c) pointed (pnt1277), principal and stellate cells of initial and transitional segments only; (d) corto (corto07128), stellate cells only; (e) teashirt (tsh04319, a kind gift of H. Skaer), stellate cells only; (f) bunched (bnc00255), principal cells, whole tubule; (g) cut (immunocytochemistry, antibody a kind gift of Jan lab), whole tubule, principal cells only; (h) CG7417 (CG7417201), lower tubule (and midgut - strong); (i) arc (a), lower tubule, not ureter; (j) Stat92E06346, all tubule cells and midgut.
Genes with known significance to tubule function, but very low abundance/enrichment scores
| Gene name | Signal | Enrichment |
| 1 ± 0 | 0.2 ± 0.04 | |
| 9 ± 2 | 0.03 ± 0.01 | |
| 3 ± 1 | 0.02 ± 0.01 |
Drosophila tubule as a model for human genetic disease
| Gene | Affymetrix signal | Enrichment | Blast probability | OMIM reference | Human disease | Available fly stocks |
| 290 ± 25 | 28.3 | 1.00E-184 | 171050 | Colchicine resistance | ||
| 99 ± 4 | 26.9 | 2.00E-40 | 253000 | Mucopolysaccharidosis IVA | ||
| 1,302 ± 112 | 14.2 | 1.00E-76 | 600359 | Bartter syndrome, antenatal, 601678 | ||
| 655 ± 44 | 13.0 | 1.00E-184 | 607633 | Xanthinuria, type I, 278300 | ||
| 183 ± 8 | 12.7 | 6.00E-38 | 602669 | Anterior segment mesenchymal dysgenesis and cataract, 107250 | ||
| 131 ± 11 | 12.0 | 9.00E-27 | 136132 | [Fish-odor syndrome], 602079 | ||
| 504 ± 50 | 12.0 | 1.00E-49 | 606202 | Oculocutaneous albinism, type IV, 606574 | ||
| 759 ± 54 | 10.6 | 1.00E-123 | 603470 | Citrullinemia, 215700 | ||
| 355 ± 40 | 9.0 | 1.00E-42 | 107400 | Emphysema; emphysema-cirrhosis, hemorrhagic diathesis due to | ||
| 825 ± 49 | 8.5 | 1.00E-69 | 607042 | Ceroid-lipofuscinosis, neuronal-3, juvenile, 204200 | ||
| 1,008 ± 70 | 8.3 | 1.00E-27 | 107910 | Gynecomastia, familial, due to increased aromatase activity | ||
| 1,364 ± 50 | 7.4 | 1.00E-153 | 137150 | GABA-transaminase deficiency | ||
| 894 ± 26 | 7.3 | 1.00E-176 | 245050 | Ketoacidosis due to SCOT deficiency | ||
| 860 ± 34 | 7.0 | 1.00E-164 | 231670 | Glutaricaciduria, type I | ||
| 2,665 ± 152 | 6.9 | 1.00E-111 | 172471 | Glycogenosis, hepatic, autosomal | ||
| 382 ± 37 | 6.8 | 4.00E-28 | 606598 | Charcot-Marie-Tooth disease, mixed axonal and demyelinating | l(3)j7B3 | |
| 203 ± 17 | 6.7 | 5.00E-40 | 138033 | |||
| 221 ± 12 | 6.4 | 6.00E-12 | 602851 | Convulsions, familial febrile, 4, 604352 | ||
| 101 ± 0 | 6.4 | 1.00E-108 | 602235 | Epilepsy, benign, neonatal, type 1, 121200; myokymia with neonatal | ||
| 852 ± 28 | 5.7 | 6.00E-74 | 606272 | Cystinosis, atypical nephropathic; cystinosis, late-onset juvenile | ||
| 168 ± 6 | 5.6 | 3.00E-27 | 300180 | Chondrodysplasia punctata, X-linked recessive, 302950 | ||
| 724 ± 39 | 5.1 | 2.00E-88 | 604285 | Hyperoxaluria, primary, type 1, 259900 | EP(x)1365 | |
| 1,001 ± 44 | 4.9 | 1.00E-100 | 605248 | Mucolipidosis IV, 252650 | ||
| 59 ± 13 | 4.9 | 2.00E-33 | 131244 | ABCD syndrome, 600501; Hirschsprung disease-2, 600155 | ||
| 911 ± 142 | 4.8 | 1.00E-100 | 113530 | Hypervalinemia or hyperleucine-isoleucinemia (?) | ||
| 531 ± 34 | 4.7 | 1.00E-184 | 603345 | Renal tubular acidosis, proximal, with ocular abnormalities, 604278 | ||
| 3441 ± 106 | 4.3 | 8.00E-80 | 130410 | Glutaricaciduria, type IIB, 231680 | EP(2)2553, l(2)k00405 | |
| 294 ± 26 | 4.2 | 6.00E-69 | 164770 | Myeloid malignancy, predisposition to | ||
| 887 ± 51 | 4.1 | 1.00E-124 | 606953 | Galactose epimerase deficiency, 230350 | ||
| 239 ± 25 | 4.0 | 1.00E-184 | 171060 | Cholestasis, familial intrahepatic, of pregnancy, 147480 | l(2)k05224 | |
| 563 ± 19 | 4.0 | 1.00E-129 | 271980 | Succinic semialdehyde dehydrogenase deficiency | EP(2)2545, l(2)k08713 | |
| 774 ± 16 | 3.9 | 4.00E-40 | 124050 | |||
| 183 ± 14 | 3.8 | 1.00E-142 | 248510 | Mannosidosis, beta- | l(2)k10108 | |
| 463 ± 24 | 3.8 | 1.00E-184 | 274270 | Thymine-uraciluria | ||
| 73 ± 5 | 3.8 | 2.00E-34 | 124080 | Aldosterone to renin ratio raised; hypoaldosteronism, congenital, | ||
| 724 ± 29 | 3.7 | 1.00E-163 | 162150 | Obesity with impaired prohormone processing, 600955 | ||
| 258 ± 14 | 3.7 | 7.00E-53 | 274180 | Thromboxane synthase deficiency | l(3)05545 | |
| 318 ± 16 | 3.6 | 1.00E-37 | 154050 | Cataract, polymorphic and lamellar, 604219 | ||
| 274 ± 29 | 3.6 | 2.00E-62 | 607096 | Hypouricemia, renal, 220150 | ||
| 1,700 ± 60 | 3.6 | 1.00E-69 | 124010 | CYP3A4 promoter polymorphism; CYP3A4-V | ||
| 239 ± 21 | 3.5 | 5.00E-29 | 313700 | Androgen insensitivity, 300068; breast cancer, male | EP(3)3340 | |
| 94 ± 7 | 3.4 | 5.00E-20 | 222745 | DECR deficiency (2) (?) | ||
| 877 ± 20 | 3.4 | 1.00E-118 | 606999 | Galactosemia, 230400 | ||
| 502 ± 31 | 3.2 | 3.00E-71 | 154550 | Carbohydrate-deficient glycoprotein syndrome, type Ib, 602579 | EP(2)0844, EP(2)2192, EP(2)2358, l(2)05428, l(2)k06503 | |
| 439 ± 14 | 3.2 | 2.00E-29 | 601789 | Adrenoleukodystrophy, neonatal, 202370; Zellweger syndrome, 214100 | ||
| 4,316 ± 88 | 3.2 | 1.00E-184 | 115500 | Acatalasemia | ||
| Prominin-like | 308 ± 24 | 3.0 | 1.00E-20 | 604365 | Retinal degeneration, autosomal recessive, prominin-related | EP(2)0740 |
Genes that are abundant (Affymetrix signal > 50) and enriched (> 3 times) in tubule, and which are also closely similar (Blast probablility < 10-20) to genes mutated in human genetic diseases, as described in the Homophila database [99]. OMIM reference refers to entries in the Online Mendelian Inheritance in Man database [100].
Figure 5Recapitulation of human xanthinuria type 1 by rosy mutants. (a) Wild-type tubule; (b) tubule from adult ry2 homozygous fly. Both micrographs are at the same magnification, and the diameter of the wild-type tubule can be taken as 35 μm.
Figure 6Summary of major genes enriched in tubule. Genes shown are upregulated at least threefold.